Publication:
Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis

dc.contributor.authorCruz, Israel
dc.contributor.authorChicharro, Carmen
dc.contributor.authorNieto Martinez, Francisco Javier
dc.contributor.authorBailo-Barroso, Begoña
dc.contributor.authorCañavate, Carmen
dc.contributor.authorFigueras, María-Concepción
dc.contributor.authorAlvar, Jorge
dc.contributor.funderGilead Sciences (Spain)es_ES
dc.contributor.funderWorld Health Organization (WHO/OMS)es_ES
dc.contributor.funderRETICS-Investigación colaborativa en Enfermedades Tropicales (RICET-ISCIII) (España)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.date.accessioned2024-02-05T10:55:13Z
dc.date.available2024-02-05T10:55:13Z
dc.date.issued2006-07
dc.description.abstractNew techniques are available for diagnosing leishmaniasis, but their efficacy in the identification of pediatric visceral leishmaniasis (VL) has not been compared with that of traditional methods. Blood, bone marrow, and urine samples were taken from 25 children with VL during their first clinical episode, 22 days after the start of treatment with liposomal amphotericin B (3 mg/kg/day on 6 days over a 10-day period), and when a relapse was suspected during follow-up. The results obtained suggest that antibody detection techniques, the antigen detection in urine (KAtex kit), and Leishmania nested PCR (LnPCR) analysis of the blood could be used for diagnosis of the first clinical episode. After treatment, clinical improvement was associated with negativization of Novy-MacNeal-Nicolle culture and microscopy of bone marrow aspirate, KAtex test, and LnPCR blood analysis results. Interestingly, LnPCR analysis of the bone marrow aspirate showed that sterile cure was not achieved in eight patients, two of which suffered a relapse within 10 to 20 weeks. All of the new noninvasive techniques tested showed high diagnostic sensitivity. However, LnPCR analysis of the bone marrow was the most sensitive; this test was able to detect the persistence of parasites and predict potential relapses.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by an agreement between Gilead Biosciencies (Spain) and the WHO Collaborating Centre for Leishmaniasis-Centro Nacional de Microbiología-Instituto de Salud Carlos III (Spain). Israel Cruz was supported by a grant from the Red de Investigación de Centros de Enfermedades Tropicales (RICET), FIS C03/04. Carmen Chicharro was supported by Intramural Project-ISCIII-TRPY-1013.es_ES
dc.format.number7es_ES
dc.format.page2343-2347es_ES
dc.format.volume44es_ES
dc.identifier.citationJ Clin Microbiol. 2006 Jul;44(7):2343-7.es_ES
dc.identifier.doi10.1128/JCM.02297-05es_ES
dc.identifier.issn0095-1137es_ES
dc.identifier.journalJournal of clinical microbiologyes_ES
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489479/
dc.identifier.pubmedID16825347es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17460
dc.language.isoenges_ES
dc.publisherAmerican Society for Microbiology (ASM)es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/FISC03/04es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/TRPY1013es_ES
dc.relation.publisherversionhttps://doi.org/10.1128/JCM.02297-05es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAmphotericin Bes_ES
dc.subject.meshAnimalses_ES
dc.subject.meshAntibodies, Protozoanes_ES
dc.subject.meshAntigens, Protozoanes_ES
dc.subject.meshAntiprotozoal Agentses_ES
dc.subject.meshBloodes_ES
dc.subject.meshBone Marrowes_ES
dc.subject.meshChildes_ES
dc.subject.meshChild, Preschooles_ES
dc.subject.meshDNA, Protozoanes_ES
dc.subject.meshFemalees_ES
dc.subject.meshHumanses_ES
dc.subject.meshImmunoassayes_ES
dc.subject.meshInfantes_ES
dc.subject.meshLeishmania infantumes_ES
dc.subject.meshLeishmaniasis, Viscerales_ES
dc.subject.meshMalees_ES
dc.subject.meshPolymerase Chain Reactiones_ES
dc.subject.meshRecurrencees_ES
dc.titleComparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasises_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication4ca3b46e-2faa-4a7d-a134-d198c24d7475
relation.isAuthorOfPublication6f88e6f5-6782-4691-8e3a-775581a76358
relation.isAuthorOfPublicationb3dc07dc-ad41-46f7-b8a2-9446c6cab831
relation.isAuthorOfPublication86922b65-f77f-4297-8499-ce852f8a9cf8
relation.isAuthorOfPublicationa516ec77-01ab-401d-b750-215d5e6a3cde
relation.isAuthorOfPublicationfaf025ec-ca8d-4d79-a19d-d37e62308551
relation.isAuthorOfPublication.latestForDiscovery4ca3b46e-2faa-4a7d-a134-d198c24d7475

Files